After activation of CD4+ T cells, they differentiate into Th1 cells producing IL-2 and IFN-γ, whereas CD8+ cytotoxic T lymphocytes (CTLs) synthesize granzyme and perforin to eliminate tumor cells presenting cognate antigens (19–21). The gene discussed is PRF1; the disease is neoplasm.